期刊文献+

临床腋淋巴结阳性乳腺癌患者行全腋窝淋巴结清扫的应用探讨 被引量:4

The clinical research of axillary lymph node dissection in breast cancer with apparent clinical axillary lymph node
下载PDF
导出
摘要 背景与目的:临床腋淋巴结阳性乳腺癌患者常规行全腋窝淋巴结清扫,本研究探讨改良根治术时采用改进L3组淋巴结清扫方式的临床应用及意义。方法:322例临床腋淋巴结阳性的乳腺癌患者中,154例采用改进的L3组淋巴结清扫方式,168例行常规Auchinclos改良根治术,对两种手术方式所用时间和术后不良反应进行比较,同时随访观察患者的无病生存率。结果:两种手术方式所用手术时间、术后不良反应差异无统计学意义(P>0.05),行改进术式患者腋下淋巴结总数及L3组淋巴结数较常规术式多,两组差异有统计学意义(P<0.05),L3组淋巴结未转移患者5年无病生存率为68.6%,L3组淋巴结转移患者5年无病生存率为35.7%,差异有统计学意义(P<0.05)。结论:对临床腋淋巴结阳性乳腺癌患者行L3组淋巴结清扫具有一定的临床应用价值,采用改进的淋巴结清扫方式,便于L3组淋巴结的清扫。 Background and purpose:Breast cancer patients with clinically apparent axillary lymph nodes were always treated with axillary lymph node dissection,the purpose of this study was to identify the clinic application and significance of modified radical mastectomy about improved ter-group axillary lymph node dissection.Methods:In this study,322 patients with clinically apparent axillary lymph nodes were collected,154 patients were operated by improved ter-group axillary lymph node dissection,168 patients were operated with regular axillary lymph node dissection.Results:The difference of the 2 types of surgery has no statistical significance in operative time and side effect(P〉0.05),but has statistical significance in axillary lymph nodes and ter-group axillary lymph nodes(P〈0.05).Five-year disease-free survival of patients with negative ter-group axillary lymph was 68.6%,and for the positive was 35.7%,the difference of the 2 surgical methods has statistical significance(P〈0.05).Conclusion:There are specified clinically meaning for patients with clinically apparent axillary lymph nodes,they were operated by improved ter-group axillary lymph node dissection,and this will make it easy in dissect ter-group axillary lymph nodes.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2011年第9期713-716,共4页 China Oncology
关键词 乳腺癌 腋淋巴结临床阳性 L3淋巴结清扫方式 Breast cancer Apparent axillary lymph node Ter-group axillary lymph node dissection
  • 相关文献

参考文献7

  • 1SAUERBREI W,ROYSTON P,BOJAR H,et al.Modelling the effects of standard prognostic factors in node positive breast cancer.German Breast Cancer Study Group(GBSG)[J].Br J Cancer,1999,79(11-12): 1752-1760.
  • 2WOODWARD W A,VINH-HUNG V,UENO N T,et al.Prognostic value of nodal ratios in node-positive breast cancer[J].J Clin Oncol,24(18): 2910-2916.
  • 3TRUONG P T,BERTHELET E,LEE J,et al.The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes[J].Cancer,2005,103(10): 2006-2014.
  • 4TAI P,JOSEPH K,SADIKOV E,et al.Nodal ratios in node positive breast cancer-long term study to clarify discrepancy of role of supraclavicular and axillary regional radiotherapy[J].Int J Radiat Oncol Biol Phys,68(3): 662-666.
  • 5MARTIN J K.Axillary dissection[J].Operative Techniques Gen Surg,2000,2(2): 152-160.
  • 6陈侃,季巧金,周冠年.乳癌Ⅲ区淋巴结清扫的临床意义[J].中华普通外科杂志,2006,21(10):747-748. 被引量:11
  • 7KODAMA H,NIO Y,IGUCHI C,et al.Ten-year follow-up results of a randomised controlled study comparing level-Ⅰ vs level-Ⅲ axillary lymph node dissection for primary breast cancer[J].Brit J Cancer,95:811-816.

二级参考文献3

  • 1高道利,徐望红,王文婉,叶儒英,丁惠芬,许培舫.乳腺癌的肿块大小、部位、病理与腋淋巴结转移及生存率的关系[J].肿瘤,1997,17(3):164-166. 被引量:11
  • 2Smillie T,Hayashi A,Rusnak C,et al.Evaluation of feasibility and accuracy of sentinel node biopsy in early breast cancer.Am J Surg,2001,181:427-430.
  • 3Fisher B,Redmond C,Poisson R,et al.Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.N Engl J Med,1989,320:822-828.

共引文献10

同被引文献47

  • 1曾健,吴武军,蒋伟哲,陆云飞.活性碳微粒对乳腺癌腋窝淋巴结清扫的临床意义[J].医师进修杂志(外科版),2004,27(6):9-11. 被引量:4
  • 2周洪伟,曾晓华,余永康,王志刚.超声刀在乳腺癌根治术中的临床应用研究[J].临床超声医学杂志,2004,6(4):213-215. 被引量:16
  • 3王为忠,郑建勇,管文贤,董光龙,张洪伟,陈冬利.腹腔镜结肠直肠癌切除术(附35例报告)[J].外科理论与实践,2004,9(6):505-506. 被引量:3
  • 4唐鹏,姜军,杨新华,范林军,张毅,张帆,钟玲.影响乳腺癌改良根治术后复发转移的临床病理因素分析[J].第三军医大学学报,2007,29(11):1099-1101. 被引量:20
  • 5Vinh-Hung V, Verkooijen HM, Fioretta G, et al. Lymph node ra- tio as an alternative to pN staging in node-positive breast cancer [ J ]. J Clin Oncol,2009,27 (7) : 1062-1068.
  • 6Veronesi V, Paganelli G, VialeG, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer[ J]. N Engl J Med,2003,349(6) :546-553.
  • 7Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical On- cology [ J ]. J Clin Onco1,2001,19 (5) : 1539-1569.
  • 8American Joint Committee on Cancer. AJCC cancer staging manu- al. 7 edition[ M]. New York:Springer,2010:347-369.
  • 9Kodama H, Nio Y, Iguchi C, et al. Ten-year follow-up results of a randomised controlled study:comparing level-I vs level-III axillary lymph node dissection for primary breast cancer[ J]. British Jouronal of Cancer,2006,95(7) :811-816.
  • 10于金明,岳金波.乳腺癌放射治疗的新概念[J].中国实用外科杂志,2011,5(3):161-164.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部